Abemaciclib and Nivolumab for Subjects With Hepatocellular Carcinoma

Clinical trial NCT03781960 · TERMINATED

Trial details

NCT number: NCT03781960
Sponsor: Abramson Cancer Center at Penn Medicine
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2019-07-31
Primary completion: 2022-04-29
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.